Your browser doesn't support javascript.
loading
A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer.
Yamaguchi, Kazuhisa; Taniguchi, Hiroya; Komori, Azusa; Narita, Yukiya; Nitta, Sohei; Nomura, Motoo; Kadowaki, Shigenori; Takahari, Daisuke; Ura, Takashi; Andoh, Masashi; Muro, Kei; Mori, Keita; Igarashi, Yoshinori.
Afiliação
  • Yamaguchi K; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. kazuhisa.yamaguchi@med.toho-u.ac.jp.
  • Taniguchi H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Omori Medical Center, 6-11-1 Omorinishi, Ota-ku, 143-8541, Tokyo, Japan. kazuhisa.yamaguchi@med.toho-u.ac.jp.
  • Komori A; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. h.taniguchi@aichi-cc.jp.
  • Narita Y; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. a.komori@aichi-cc.jp.
  • Nitta S; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. yukiya.narita@aichi-cc.jp.
  • Nomura M; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. shntt2@gmail.com.
  • Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. mnomura@aichi-cc.jp.
  • Takahari D; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. skadowaki@aichi-cc.jp.
  • Ura T; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. daisuke.takahari@jfcr.or.jp.
  • Andoh M; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. tura@aichi-cc.jp.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. mandoh@aichi-cc.jp.
  • Mori K; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Aichi, Japan. kmuro@aichi-cc.jp.
  • Igarashi Y; Division of Clinical Research Promotion Office, Depertment of Clinical, Research Support Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, 411-8777, Shizuoka, Japan. ke.mori@acchr.jp.
BMC Cancer ; 15: 601, 2015 Aug 27.
Article em En | MEDLINE | ID: mdl-26311588
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Neoplasias Colorretais / Leucovorina / Tegafur / Bevacizumab Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Neoplasias Colorretais / Leucovorina / Tegafur / Bevacizumab Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article